Since Mar, due to Omicron in China, all deliveries to China patients were significantly impacted, it’s the worst situation ever met in the past 3 COVID-19 years. To serve our customers better, we are going to build some stocks in China for emergencies. Any updates will keep in tune.
Ensartinib significantly prolonged progression-free survival, compared with crizotinib, in patients with ALK-positive non-small-cell lung cancer (NSCLC) in the eXalt3 study. Ensartinib, being developed by Xcovery Holdings, is a potent, next-generation, once-daily oral ALK inhibitor with broad preclinical activity against ALK-resistance mutations. “Its potency is more than 10 times greater than that of crizotinib in enzyme… Read More »Ensartinib Bests Crizotinib in ALK+ Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved a new, faster diagnostic test based on bacterial viability and a novel technology to detect methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization, a common cause of hospital-acquired infections. The cobas vivoDx MRSA diagnostic test, from Roche Molecular Systems, may allow healthcare providers to evaluate patients for colonization with MRSA bacteria… Read More »FDA Clears Faster Diagnostic Test for MRSA
Have you ever been advised to take a medicine with food? How about taking a medicine with cola or avoiding grapefruit? Hundreds of medicines have food-related dosing instructions. With four out of five Australians aged above 50 taking daily medication, most people will encounter instructions about medicines and food at some point in their lives –… Read More »why must some medications be taken with food?